Carceres Inc. is a Pharmaceutical research and development company with three new products in the fourth year of development. These products should be eligible for patent protection by 2026.
Although the company will not have significant new product revenues until 2021, the new product pipeline is expected to produce $50 Million in 2022, and revenues in excess of $120 Million is projected by 2026. All three pipeline products have huge markets and will generate substantial returns.
The company is currently seeking an equity partner to invest $18 Million for a 30% ownership stake. The proceeds will be used for clinical testing and approval processes for the three pipeline products, and $3 Million will be available for distribution to current stakeholders.
Sales Not Disclosed
Asking Price $18,000,000
Profits Not Disclosed
DEAL TERMS WILL BE DISCLOSED TO ACCREDITED INVESTORS ONLY
Are you an accredited investor?
For an individual to qualify as an accredited investor, one of two conditions must be met:
- The individual must have earned income exceeding $200,000, or $300,000 when combined with a spouse, during each of the previous two full calendar years, and a reasonable expectation of the same for the current year. The same method (single or joint) must be applied to the income test in all three years.
- The individual must have a net worth greater than $1 million (either alone or combined with a spouse), excluding the person’s primary residence. We have a net worth calculator that can help you determine yours — just leave the “residence” input at zero for accredited investor purposes.
It’s just not individuals that can be accredited investors. Banks, partnerships, corporations, nonprofits, and trusts can, too. For example, a trust with assets greater than $5 million or any entity whose owners are all accredited investors would qualify.